International Journal of Infectious Diseases
Volume 14, Issue 10 , Pages e857-e867 , October 2010

Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells

  • Rajkumar Cheluvappa

      Affiliations

    • Department of Medicine, St. George Clinical School and Centre for Infection and Inflammation Research, School of Medical Sciences, Wallace Wurth Building, University of New South Wales, Gate 9 High Street, Sydney, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 0406 0406 20; fax: +61 02 9385 1389.
    • ,
  • Gerene M. Denning

      Affiliations

    • Department of Emergency Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
    • ,
  • Gee W. Lau

      Affiliations

    • Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
    • ,
  • Michael C. Grimm

      Affiliations

    • Department of Medicine, St. George Clinical School and Centre for Infection and Inflammation Research, School of Medical Sciences, Wallace Wurth Building, University of New South Wales, Gate 9 High Street, Sydney, NSW 2052, Australia
    • ,
  • Sarah N. Hilmer

      Affiliations

    • Centre for Education and Research on Aging and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Concord, New South Wales, Australia
    • Departments of Aged Care and Clinical Pharmacology, Royal North Shore Hospital, St Leonards, New South Wales, Australia
    • ,
  • David G. Le Couteur

      Affiliations

    • Centre for Education and Research on Aging and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Concord, New South Wales, Australia

Received 8 May 2009 ,Revised 30 November 2009 ,Accepted 25 February 2010.

References 

  1. Soave R, Murray HW, Litrenta MM. Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med. 1978;65:864–867
  2. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun. 2007;75:3715–3721
  3. Fetzer AE, Werner AS, Hagstrom JW. Pathologic features of pseudomonal pneumonia. Am Rev Respir Dis. 1967;96:1121–1130
  4. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol. 1990;26:265–274
  5. Valente E, Assis MC, Alvim IM, Pereira GM, Plotkowski MC. Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb Pathog. 2000;29:345–356
  6. Britigan BE, Rasmussen GT, Cox CD. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun. 1997;65:1071–1076
  7. Hassan HM, Fridovich I. Mechanism of the antibiotic action of pyocyanine. J Bacteriol. 1980;141:156–163
  8. Muller M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Rad Biol Med. 2002;33:1527–1533
  9. Muhlradt PF, Tsai H, Conradt P. Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity. Eur J Immunol. 1986;16:434–440
  10. Muller PK, Krohn K, Muhlradt PF. Effects of pyocyanine, a phenazine dye from Pseudomonas aeruginosa, on oxidative burst and bacterial killing in human neutrophils. Infect Immun. 1989;57:2591–2596
  11. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun. 2004;72:4275–4278
  12. Harman JW, Macbrinn MC. The effect of phenazine methosulphate, pyocyanine and EDTA on mitochondrial succinic dehydrogenase. Biochem Pharmacol. 1963;12:1265–1278
  13. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, Taylor GW, et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol. 2002;168:1861–1868
  14. Muller M. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. Free Radic Biol Med. 2006;41:1670–1677
  15. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest. 1992;90:2187–2196
  16. Cheluvappa R, Jamieson HA, Hilmer SN, Muller M, Le Couteur DG. The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J Gastroenterol Hepatol. 2007;22:1350–1351
  17. Cogger VC, Mross PE, Hosie MJ, Ansselin AD, McLean AJ, Le Couteur DG. The effect of acute oxidative stress on the ultrastructure of the perfused rat liver. Pharmacol Toxicol. 2001;89:306–311
  18. Dobbs BR, Rogers GW, Xing HY, Fraser R. Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis?. Liver. 1994;14:230–233
  19. Seto S, Kaido T, Yamaoka S, Yoshikawa A, Arii S, Nakamura T, et al. Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res. 1998;80:194–199
  20. Cheluvappa R, Cogger VC, Kwun SY, O’Reilly JN, Le Couteur DG, Hilmer SN. Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol. 2008;89:410–418
  21. Sumitran-Holgersson S, Ge X, Karrar A, Xu B, Nava S, Broome U, et al. A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology. 2004;40:1211–1221
  22. Fraser R, Dobbs BR, Rogers GW. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology. 1995;21:863–874
  23. Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet. 2005;44:187–200
  24. Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbe E, et al. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol. 1996;24:100–111
  25. Wake K, Decker K, Kirn A, Knook DL, McCuskey RS, Bouwens L, et al. Cell biology and kinetics of Kupffer cells in the liver. Int Rev Cytol. 1989;118:173–229
  26. Bouwens L. Structural and functional aspects of Kupffer cells. Revis Biol Celular. 1988;16:69–94
  27. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161(III–XIII):1–151
  28. Bouwens L, De Bleser P, Vanderkerken K, Geerts B, Wisse E. Liver cell heterogeneity: functions of non-parenchymal cells. Enzyme. 1992;46:155–168
  29. Wisse W, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology. 1985;5:683–692
  30. Henriksen JH, Horn T, Christoffersen P. The blood–lymph barrier in the liver. A review based on morphological and functional concepts of normal and cirrhotic liver. Liver. 1984;4:221–232
  31. Braet F, De Zanger R, Crabbe E, Wisse E. New observations on cytoskeleton and fenestrae in isolated rat liver sinusoidal endothelial cells. J Gastroenterol Hepatol. 1995;10(Suppl 1):S3–7
  32. Fraser R, Rogers GWT, Sutton LE, Dobbs BR. Single dose models of defenestration: tools to explore mechanisms, modulation and measurement of hepatic sinusoidal porosity. In:  Wisse E,  Knook DL,  Wake K editor. Cells of the hepatic sinusoid. vol. 5:Leiden: Kupffer Cell Foundation; 1995;p. 263–266
  33. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res. 1970;31:125–150
  34. Wisse E, De Zanger RB, Jacobs R, McCuskey RS. Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc. 1983;(Pt 3):1441–1452
  35. Horn T, Henriksen JH, Christoffersen P. The sinusoidal lining cells in ‘normal’ human liver. A scanning electron microscopic investigation. Liver. 1986;6:98–110
  36. Vidal-Vanaclocha F, Barbera-Guillem E. Fenestration patterns in endothelial cells of rat liver sinusoids. J Ultrastruct Res. 1985;90:115–123
  37. Steffan AM, Gendrault JL, Kirn A. Increase in the number of fenestrae in mouse endothelial liver cells by altering the cytoskeleton with cytochalasin B. Hepatology. 1987;7:1230–1238
  38. Braet F, De Zanger R, Baekeland M, Crabbe E, Van Der Smissen P, Wisse E. Structure and dynamics of the fenestrae-associated cytoskeleton of rat liver sinusoidal endothelial cells. Hepatology. 1995;21:180–189
  39. Oda M, Kazemoto S, Kaneko H, Yokomori H, Ishii K, Tsukada N, et al. Involvement of Ca++–calmodulin–actomyosin system in contractility of hepatic sinusoidal endothelial fenestrae. In:  Knook DI,  Wisse E editor. Cells of the hepatic sinusoid. Vol. 4:Leiden: Kupffer Cell Foundation; 1993;p. 174–178
  40. Tsukada N, Oda M, Yonei M. Alterations of the hepatic sinusoidal fenestrae in response to vasoactive substances in the rat—in vivo and in vitro studies. In:  Kirn A,  Knook DI,  Wisse E editor. Cells of the hepatic sinusoid. Vol. 1:Rijswijk: Kupffer Cell Foundation; 1986;p. 515–516
  41. Wisse E, De Zanger R, Fraser R, McCuskey RS. On the role of liver endothelial filter in the transport of particulate fat (chylomicrons and their remnants) to parenchymal cells and the influence of certain hormones on the endothelial fenestrae. In:  Popper H editors. Communications of liver cells. Lancaster: MTP Press; 1980;pp. 195–200
  42. Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM. Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol. 1996;148:2027–2041
  43. Braet F, Muller M, Vekemans K, Wisse E, Le Couteur DG. Antimycin A-induced defenestration in rat hepatic sinusoidal endothelial cells. Hepatology. 2003;38:394–402
  44. Ogino J, Yamada T, Goto R, Kikushima K, Fujimori I. [Growth inhibitory activity of clinical isolates of Pseudomonas aeruginosa against Staphylococcus aureus (MRSA and MSSA)]. Kansenshogaku Zasshi. 1992;66:909–913
  45. Charels K, De Zanger RB, Van Bossuyt H, Van Der Smissen P, Wisse W. Influence of acute alcohol administration on endothelial fenestrae of rat livers. In:  Kirn A,  Knook DI,  Wisse E editor. Cells of the hepatic sinusoid. Vol. 1:Rijswijk: Kupffer Cell Foundation; 1986;p. 497–502
  46. Mori T, Okanoue T, Sawa Y, Itoh Y, Kanaoka H, Hori N, et al. Effect of ethanol on the sinusoidal endothelial fenestrations of rat liver – in vivo an in vitro study. In:  Wisse E,  Knook DL,  McCuskey RS editor. Cells of the Hepatic Sinusoid. vol. 3:Leiden: Kupffer Cell Foundation; 1991;pp. 469–471
  47. Fraser R, Bowler LM, Day WA. Damage of rat liver sinusoidal endothelium by ethanol. Pathology. 1980;12:371–376
  48. Sarphie G, D'Souza NB, Van Thiel DH, Hill D, McClain CJ, Deaciuc IV. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res. 1997;21:1128–1136
  49. Horn T, Christoffersen P, Henriksen JH. Alcoholic liver injury: defenestration in noncirrhotic livers—a scanning electron microscopic study. Hepatology. 1987;7:77–82
  50. Clark SA, Angus HB, Cook HB, George PM, Oxner RB, Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet. 1988;2:1225–1227
  51. Nopanitaya W, Grisham JW, Carson JL, Dotson MM. Surface features of cirrhotic liver. Virchows Arch A Pathol Anat Histol. 1976;372:97–108
  52. Fraser R, Clark SA, Day WA, Murray FE. Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia. Br J Exp Pathol. 1988;69:345–350
  53. Cogger VC, Hilmer SN, Sullivan D, Muller M, Fraser R, Le Couteur DG. Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis. 2006;189:273–281
  54. Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet. 2002;359:1612–1615
  55. Walker RM, Racz WJ, McElligott TF. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am J Pathol. 1983;113:321–330
  56. Nopanitaya W, Lamb JC, Grisham JW, Carson JL. Effect of hepatic venous outflow obstruction on pores and fenestration in sinusoidal endothelium. Br J Exp Pathol. 1976;57:604–609
  57. Fraser R, Bowler LM, Day WA, Dobbs B, Johnson HD, Lee D. High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers. Br J Exp Pathol. 1980;61:222–228
  58. Jamieson HA, Cogger VC, Twigg SM, McLennan SV, Warren A, Cheluvappa R, et al. Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes. Diabetologia. 2007;50:1969–1976
  59. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52:2867–2873
  60. Le Couteur DG, Cogger VC, Markus AM, Harvey PJ, Yin ZL, Ansselin AD, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology. 2001;33:537–543
  61. Cogger VC, Warren A, Fraser R, Ngu M, McLean AJ, Le Couteur DG. Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol. 2003;38:1101–1107
  62. McLean AJ, Cogger VC, Chong GC, Warren A, Markus AM, Dahlstrom JE, et al. Age-related pseudocapillarization of the human liver. J Pathol. 2003;200:112–117
  63. Warren A, Bertolino P, Cogger VC, McLean AJ, Fraser R, Couteur DG. Hepatic pseudocapillarization in aged mice. Exp Gerontol. 2005;40:807–812
  64. Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology. 2005;42:1349–1354
  65. Mamo JC, Elsegood CL, Umeda Y, Hirano T, Redgrave TG. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb. 1993;13:231–239
  66. Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, et al. Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?. Metabolism. 2000;49:1049–1054
  67. Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol. 2006;17:238–246
  68. Naito M, Wisse E. Filtration effect of endothelial fenestrations on chylomicron transport in neonatal rat liver sinusoids. Cell Tissue Res. 1978;190:371–382
  69. Fraser R, Bosanquet AG, Day WA. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. Atherosclerosis. 1978;29:113–123
  70. Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Goto M, et al. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol. 2000;15(Suppl):D20–D25
  71. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev. 2000;174:21–34
  72. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology. 1977;72:1268–1270
  73. Ueno M. [Endotoxemia and its compensatory mechanisms in experimental liver cirrhosis]. Nippon Shokakibyo Gakkai Zasshi. 1990;87:1692–1700
  74. Knolle PA, Germann T, Treichel U, Uhrig A, Schmitt E, Hegenbarth S, et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol. 1999;162:1401–1407
  75. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology. 2006;44:1182–1190
  76. Warren A, Bertolino P, Benseler V, Fraser R, McCaughan GW, Le Couteur DG. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol. 2007;46:239–246
  77. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol. 2000;157:1671–1683
  78. Schumann J, Bluethmann H, Tiegs G. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. Immunol Lett. 2000;74:165–172
  79. Gorgen I, Hartung T, Leist M, Niehorster M, Tiegs G, Uhlig S, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 1992;149:918–924
  80. Jaeschke H, Farhood A, Fisher MA, Smith CW. Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1. Shock. 1996;6:351–356
  81. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991;260:G355–G362
  82. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol. 2002;27:23–27
  83. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166–176
  84. Enomoto N, Schemmer P, Ikejima K, Takei Y, Sato N, Brenner DA, et al. Long-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharide. Alcohol Clin Exp Res. 2001;25:1360–1367
  85. Tiegs G, Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol. 1988;37:2569–2573
  86. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1989;38:627–631
  87. Spolarics Z, Stein DS, Garcia ZC. Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells. Hepatology. 1996;24:691–696
  88. Jaeschke H. Enhanced sinusoidal glutathione efflux during endotoxin-induced oxidant stress in vivo. Am J Physiol. 1992;263:G60–G68
  89. Spolarics Z, Navarro L. Endotoxin stimulates the expression of glucose-6-phosphate dehydrogenase in Kupffer and hepatic endothelial cells. J Leukoc Biol. 1994;56:453–457
  90. Spolarics Z. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J Leuk Biol. 1998;63:534–541
  91. Yokoyama H, Mizukami T, Kamegaya Y, Fukuda M, Okamura Y, Matsumoto M, et al. Formation of superoxide anion in the hepatic sinusoid after lipopolysaccharide challenge. Alcohol Clin Exp Res. 1998;22:133S–136S
  92. Luyendyk JP, Maddox JF, Green CD, Ganey PE, Roth RA. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide–ranitidine coexposure in rats. Hepatology. 2004;40:1342–1351
  93. Luyendyk JP, Mattes WB, Burgoon LD, Zacharewski TR, Maddox JF, Cosma GN, et al. Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine. Toxicol Sci. 2004;80:203–213
  94. Copple BL, Moulin F, Hanumegowda UM, Ganey PE, Roth RA. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther. 2003;305:417–425
  95. Moulin F, Pearson JM, Schultze AE, Scott MA, Schwartz KA, Davis JM, et al. Thrombin is a distal mediator of lipopolysaccharide-induced liver injury in the rat. J Surg Res. 1996;65:149–158
  96. Kume M, Hayashi T, Yuasa H, Tanaka H, Nishioka J, Ido M, et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats—a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J Hepatol. 2003;38:9–17
  97. Pearson JM, Schultze AE, Jean PA, Roth RA. Platelet participation in liver injury from Gram-negative bacterial lipopolysaccharide in the rat. Shock. 1995;4:178–186
  98. Hewett JA, Roth RA. The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from Gram-negative bacteria. J Pharmacol Exp Ther. 1995;272:53–62
  99. Takeuchi M, Nakashima Y, Miura Y, Nakagawa K, Uragoh K, Iwanaga S, et al. The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies. Pathol Res Pract. 1994;190:1123–1133
  100. Salgia R, Becker JH, Sayeed MM. Altered membrane fluidity in rat hepatocytes during endotoxic shock. Mol Cell Biochem. 1993;121:143–148
  101. Ogle CK, Guo X, Wu JZ, Ogle JD, Fischer JE. Effect of hepatocytes from normal or endotoxin treated animals on the production of tumour necrosis factor, interleukin-6, and prostaglandin-E2 by macrophages incubated in vitro with various fatty acids. Eur J Surg. 1995;161:123–127
  102. Lang CH, Pollard V, Fan J, Traber LD, Traber DL, Frost RA, et al. Acute alterations in growth hormone–insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol. 1997;273:R371–R378
  103. Gaeta GB, Wisse E. Endotoxin effect on the isolated perfused rat liver: functional and ultrastructural observations. J Submicrosc Cytol. 1983;15:705–712
  104. Jia JB, Han DW, Xu RL, Gao F, Zhao LF, Zhao YC, et al. Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes. World J Gastroenterol. 1998;4:329–331
  105. Yee SB, Ganey PE, Roth RA. The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury. Toxicol Sci. 2003;71:124–132
  106. Luyendyk JP, Copple BL, Barton CC, Ganey PE, Roth RA. Augmentation of aflatoxin B1 hepatotoxicity by endotoxin: involvement of endothelium and the coagulation system. Toxicol Sci. 2003;72:171–181
  107. Brown AP, Schultze AE, Holdan WL, Buchweitz JP, Roth RA, Ganey PE. Lipopolysaccharide-induced hepatic injury is enhanced by polychlorinated biphenyls. Environ Health Perspect. 1996;104:634–640
  108. Roth RA, Harkema JR, Pestka JP, Ganey PE. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?. Toxicol Appl Pharmacol. 1997;147:300–311
  109. Scoazec JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology. 1991;14:789–797
  110. Knolle PA, Schmitt E, Jin S, Germann T, Duchmann R, Hegenbarth S, et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology. 1999;116:1428–1440
  111. Knolle PA, Uhrig A, Hegenbarth S, Loser E, Schmitt E, Gerken G, et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol. 1998;114:427–433
  112. Magnusson S, Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem J. 1989;257:651–656
  113. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology. 1990;12:505–510
  114. Lohse AW, Knolle PA, Bilo K, Uhrig A, Waldmann C, Ibe M, et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology. 1996;110:1175–1181
  115. Knolle PA, Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly. 2003;133:501–506
  116. Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol. 2002;169:2407–2413
  117. Limmer A, Knolle PA. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch Immunol Ther Exp (Warsz). 2001;49(Suppl 1):S7–11
  118. Limmer A, Ohl J, Wingender G, Berg M, Jungerkes F, Schumak B, et al. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol. 2005;35:2970–2981
  119. Shnyra A, Hultenby K, Lindberg AA. Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect Immun. 1993;61:5351–5360
  120. Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun. 1995;63:865–873
  121. Smedsrod B, Pertoft H, Gustafson S, Laurent TC. Scavenger functions of the liver endothelial cell. Biochem J. 1990;266:313–327
  122. Svistounov D, Smedsrod B. Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?. J Hepatol. 2004;41:1038–1040
  123. Gong JP, Dai LL, Liu CA, Wu CX, Shi YJ, Li SW, et al. Expression of CD14 protein and its gene in liver sinusoidal endothelial cells during endotoxemia. World J Gastroenterol. 2002;8:551–554
  124. Gouvea EF, Branco RC, Monteiro RC, Halpern M, Ribeiro-Filho J, Silveira VG, et al. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant Proc. 2004;36:958–960
  125. Iinuma Y, Senda K, Fujihara N, Saito T, Takakura S, Kudo T, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation. 2004;78:704–709
  126. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward Gram-negative bacteria as predominant pathogens. Liver Transpl. 2004;10:844–849
  127. Hart DW, Gore DC, Rinehart AJ, Asimakis GK, Chinkes DL. Sepsis-induced failure of hepatic energy metabolism. J Surg Res. 2003;115:139–147
  128. Hart DW, Chinkes DL, Gore DC. Increased tissue oxygen extraction and acidosis with progressive severity of sepsis. J Surg Res. 2003;112:49–58
  129. Muhlen KA, Schumann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, et al. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol. 2004;172:3034–3041
  130. Schumann J, Muhlen K, Kiemer AK, Vollmar AM, Tiegs G. Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice. J Immunol. 2003;170:2129–2137
  131. Pitt TL. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med. 1986;79(Suppl 12):13–18
  132. Wilson R, Pitt T, Taylor G, Watson D, MacDermot J, Sykes D, et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987;79:221–229
  133. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988;56:2515–2517
  134. O’Malley YQ, Reszka KJ, Spitz DR, Denning GM, Britigan BE. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L94–103
  135. Schumann J, Angermuller S, Bang R, Lohoff M, Tiegs G. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol. 1998;161:5745–5754
  136. Takei Y, Kawano S, Nishimura Y, Goto M, Nagai H, Chen SS, et al. Apoptosis: a new mechanism of endothelial and Kupffer cell killing. J Gastroenterol Hepatol. 1995;10(Suppl 1):S65–S67
  137. Sarphie TG, D'Souza NB, Deaciuc IV. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology. 1996;23:788–796
  138. Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 1996;139:213–226
  139. Leidal KG, Munson KL, Denning GM. Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells. Am J Respir Cell Mol Biol. 2001;25:186–195
  140. Rose S, Baumann H, Jahreis GP, Sayeed MM. Diltiazem and superoxide dismutase modulate hepatic acute phase response in Gram-negative sepsis. Shock. 1994;1:87–93
  141. Pedersen PV, Warner BW, Bjornson HS, Hiyama DT, Li S, Rigel DF, et al. Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats. Surg Gynecol Obstet. 1989;168:148–156
  142. Spitzer JJ, Bagby GJ, Meszaros K, Lang CH. Alterations in lipid and carbohydrate metabolism in sepsis. JPEN J Parenter Enteral Nutr. 1988;12(6 Suppl):53S–58S
  143. Spitzer JJ, Bagby GJ, Hargrove DM, Lang CH, Meszaros K. Alterations in the metabolic control of carbohydrates in sepsis. Prog Clin Biol Res. 1989;308:545–561
  144. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest. 1999;79:1181–1199
  145. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol. 1996;270:G660–G666
  146. Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock. 1995;3:56–62
  147. Landau BR, Hastings AB, Zottu S. Pyocyanin and metabolic pathways in liver slices in vitro. Biochim Biophys Acta. 1963;74:629–634
  148. Stewart-Tull DE, Armstrong AV. The effect of 1-hydroxyphenazine and pyocyanin from Pseudomonas aeruginosa on mammalian cell respiration. J Med Microbiol. 1972;5:67–73
  149. Hassett DJ, Charniga L, Bean K, Ohman DE, Cohen MS. Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun. 1992;60:328–336
  150. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa–Caenorhabditis elegans pathogenesis model. Cell. 1999;96:47–56
  151. Muller M, Sorrell TC. Oxidative stress and the mobilisation of arachidonic acid in stimulated human platelets: role of hydroxyl radical. Prostaglandins. 1997;54:493–509
  152. Ran H, Hassett DJ, Lau GW. Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci U S A. 2003;100:14315–14320
  153. Scholl RA, Lang CH, Bagby GJ. Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic. Escherichia coli bacteremic, and polymicrobial septic rats. J Surg Res. 1984;37:394–401
  154. Harris HW, Gosnell JE, Kumwenda ZL. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res. 2000;6:421–430
  155. Tiao G, Noguchi Y, Lieberman MA, Fischer JE, Hasselgren PO. Sepsis stimulates polyamine biosynthesis in the liver and increases tissue levels of ornithine decarboxylase mRNA. Shock. 1995;4:403–410
  156. Munford RS, Dietschy JM. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. J Infect Dis. 1985;152:177–184
  157. Munford RS, Hall CL, Dietschy JM. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun. 1981;34:835–843
  158. Kitano H, Fukui H, Okamoto Y, Kikuchi E, Matsumoto M, Kikukawa M, et al. Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res. 1996;20(1 Suppl):73A–76A
  159. Kitano H, Fukui H, Okamoto Y, Kikuchi E, Matsumoto M, Kikukawa M, et al. Protective mechanism of high-density lipoprotein against endotoxemia in chronic alcohol ingestion. Alcohol Clin Exp Res. 1996;20(9 Suppl):356A–359A
  160. Kumwenda ZL, Wong CB, Johnson JA, Gosnell JE, Welch WJ, Harris HW. Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock. 2002;18:182–188
  161. Read TE, Grunfeld C, Kumwenda ZL, Calhoun MC, Kane JP, Feingold KR, et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med. 1995;182:267–272
  162. Sun X, Kimura T, Kobayashi T, Noriki S, Imamura Y, Fukuda M, et al. Viability of liver grafts from fasted donor rats: relationship to sinusoidal endothelial cell apoptosis. J Hepatobiliary Pancreat Surg. 2001;8:268–273
  163. Shimizu H, Miyazaki M, Ito H, Nakagawa K, Ambiru S, Kato A, et al. Mechanism of cold ischemia-reperfusion-induced graft injury after orthotopic liver transplantation in rats. Hepatogastroenterology. 2001;48:216–219
  164. Fraser R, Day WA, Fernando NS. Atherosclerosis and the liver sieve. In:  Kirn A,  Knook DL,  Wisse E editor. Cells of the Hepatic Sinusoid. Vol. 1:Rijswijk: The Kupffer Cell Foundation; 1986;p. 317–322
  165. Deleve LD. Hepatic microvasculature in liver injury. Semin Liver Dis. 2007;27:390–400
  166. Deaciuc IV, Spitzer JA. Calcium content in liver and heart and its intracellular distribution in liver during endotoxicosis and sepsis in rats. Cell Calcium. 1987;8:365–376
  167. Sayeed MM, Maitra SR. Effect of diltiazem on altered cellular calcium regulation during endotoxic shock. Am J Physiol. 1987;253:R549–R554
  168. Mustafa SB, Olson MS. Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression. Am J Physiol. 1999;277:G351–G360
  169. Liu P, Fisher MA, Farhood A, Smith CW, Jaeschke H. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock. 1994;43:64–70
  170. Wojnar MM, Hawkins WG, Lang CH. Nutritional support of the septic patient. Crit Care Clin. 1995;11:717–733
  171. Oda M, Kamegaya Y, Yokomori H, Han JY, Akiba Y, Nakumura M, et al. Roles of plasma membrane Ca++-ATPase in the relaxation and contraction of hepatic sinusoidal endothelial fenestrae—effects of prostaglandin E1 and endothelin 1. In:  Wisse E,  Knook DL,  Balabaud C editor. Cells of the Hepatic Sinusoid. vol. 6:Leiden: Kupffer Cell Foundation; 1997;p. 313–317
  172. Watanabe N, Takashimizu S, Nishizaki Y, Kojima S, Kagawa T, Matsuzaki S. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation. J Gastroenterol. 2007;42:775–782
  173. Fraser R, Clark SA, Bowler LM, Murray FEM, Wakasugi J, Ishihara M, et al. The opposite effects of nicotine and pantethine on the porosity of the liver sieve and lipoprotein metabolism. In:  Wisse E,  Knook DL,  Decker K editor. Cells of the Hepatic Sinusoid. vol. 2:Leiden: Kupffer Cell Foundation; 1989;p. 335–338
  174. Doria C, Marino IR. Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation. Exp Clin Transplant. 2005;3:289–292
  175. Ma YK, Yan LN, Li B, Lu SC, Huang AH, Wen TF, et al. Diagnosis and treatment of bacterial pneumonia in liver transplantation recipients: report of 33 cases. Chin Med J (Engl). 2005;118:1879–1885
  176. Aduen JF, Hellinger WC, Kramer DJ, Stapelfeldt WH, Bonatti H, Crook JE, et al. Spectrum of pneumonia in the current era of liver transplantation and its effect on survival. Mayo Clin Proc. 2005;80:1303–1306
  177. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl. 2001;7:22–26
  178. Singh N, Gayowski T, Wagener MM, Marino IR. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation. 1999;67:1138–1144
  179. Couetil JP, Houssin DP, Soubrane O, Chevalier PG, Dousset BE, Loulmet D, et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg. 1995;110:1415–1422discussion 22–3
  180. Wade J, Rolando N, Williams R. The significance of aerobic Gram-negative bacilli in clinical specimens following orthotopic liver transplantation. Liver Transpl Surg. 1998;4:51–57
  181. Moreno A, Mensa J, Almela M, Vilardell J, Navasa M, Claramonte J, et al. [138 episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation]. Med Clin (Barc). 1994;103:161–164
  182. Cuervas-Mons V, Julio Martinez A, Dekker A, Starzl TE, Van Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology. 1986;6:495–501
  183. Spector I, Braet F, Shochet NR, Bubb MR. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech. 1999;47:18–37
  184. Braet F, De Zanger R, Jans D, Spector I, Wisse E. Microfilament-disrupting agent latrunculin A induces an increased number of fenestrae in rat liver sinusoidal endothelial cells: comparison with cytochalasin B. Hepatology. 1996;24:627–635
  185. Braet F, Spector I, De Zanger R, Wisse E. A novel structure involved in the formation of liver endothelial cell fenestrae revealed by using the actin inhibitor misakinolide. Proc Natl Acad Sci U S A. 1998;95:13635–13640
  186. Braet F, Spector I, Shochet N, Crews P, Higa T, Menu E, et al. The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells. BMC Cell Biol. 2002;3:7
  187. Le Couteur DG, Warren A, Cogger VC, Smedsrod B, Sorensen KK, De Cabo R, et al. Old age and the hepatic sinusoid. Anat Rec (Hoboken). 2008;291:672–683

PII: S1201-9712(10)02398-2

doi: 10.1016/j.ijid.2010.02.2263

International Journal of Infectious Diseases
Volume 14, Issue 10 , Pages e857-e867 , October 2010

Article Tools

* Image Usage & Resolution